Posts in category: Type I
Diabetic Ketoacidosis May Affect Children’s Brain Development

Recent studies have shown that even a single episode of diabetic ketoacidosis in young children with type 1 diabetes is associated with lower cognitive scores and altered brain growth; more research is needed to determine the scope of the problem and h…

Count Protein, Fat as well as Carbs in Insulin Calculations

People with type 1 diabetes are usually advised only to count the carbohydrate content of their meal when calculating pre-meal insulin dose. While this improves glycemic management, there is growing evidence that protein and fat should also be consider…

Only 1 in 5 with Type 1 Meet Blood Glucose Goals

New data says that only about one in five Americans with type 1 diabetes is achieving optimal glycemic control. This is in spite of the increased use of technologies such as insulin pumps and continuous glucose monitors (CGMs) designed to help with dia…

Rotavirus Vaccine May Help Prevent Type 1

A recent drop in type 1 diabetes rates in Australian children may be linked to the introduction of a routine vaccine against rotavirus. Researchers in Melbourne found that diabetes rates have been declining in infants since the vaccine’s launch in Aust…

FDA Panel in Disagreement about New Type 1 Drug

Members of an FDA panel assessing whether to approve Sanofi’s new drug, Zynquista, could not agree. On January 17, 2019, the panel was evenly split, 8-8, on whether the drug’s benefits outweighed its risks. The drug will receive its verdict from …

New Type of Drug Shows Promise in Type 1

Subetta is a new drug currently under review for approval by the FDA and undergoing phase 3 clinical trials. By activating insulin receptors, Subetta has an antihyperglycemic effect, stimulating uptake of glucose by muscle cells. The trials suggest Sub…

Cannabis May Be Dangerous to People with Type 1 Diabetes

There has been little research to date on how cannabis use might affect people with type 1 diabetes. A new study of people with type 1 in Colorado, where cannabis use is legal,  says they may be more likely to develop potentially fatal complications wh…

Good Blood Sugar Control Can Help Reduce Dementia Risk in Type 1

Poor blood sugar control has been implicated in dementia for people with type 2 diabetes. A new study looked at dementia risk for type 1 diabetes, and found that good glycemic management can help maintain cognitive function in people who have type 1 di…

Good Blood Sugar Control Can Help Reduce Dementia Risk in Type 1

Poor blood sugar control has been implicated in dementia for people with type 2 diabetes. A new study looked at dementia risk for type 1 diabetes, and found that good glycemic management can help maintain cognitive function in people who have type 1 di…

Sotagliflozin for Type 1 Diabetes

A new drug called sotagliflozin is a dual inhibitor of SGLT-1 and SGLT-2, which means it helps limits the body’s absorption of excess glucose through both the intestines and the kidneys. A new study looked at the safety and efficacy of the drug a…